SARS-COV-2 mRNA vaccines improve clinical responses to immune checkpoint inhibition
In a new study, researchers have identified benefits of SARS-COV-2 mRNA vaccines for cancer patients undergoing immunotherapy. The...
SARS-COV-2 mRNA vaccines improve clinical responses to immune checkpoint inhibition
Inherited gene mutations raise melanoma risk more than thought, study finds
Plasma biomarker may identify response to PD-1 inhibitor Tx for melanoma
Melanoma vaccine enters international trial phase
Modulating the gut microbiome may improve response to ICB therapy
AI system identifies melanoma in early stages
Potential Tx to prevent melanoma metastasis identified
Combination therapy of benefit in metastatic melanoma